SCHEMBL22657384

SCHEMBL22657384

CCC(C)(N)CCC(C)O

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
HIF1A Q16665 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8367700 0.80 TRPM8 (0.30)
SCHEMBL8368986 0.78
SCHEMBL10621136 0.78 TSHR (0.36) TSHR
SCHEMBL8670869 0.78 OPRM1 (0.39)
SCHEMBL21288517 0.77
SCHEMBL277179 0.76 MEN1 (0.38) CYP3A4
SCHEMBL13060863 0.75 TSHR (0.38) TSHRMAPK1
SCHEMBL1660032 0.75 TSHR (0.38) TSHRMAPK1
SCHEMBL29165445 0.75
SCHEMBL10803129 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524973-B2 Metal compounds and methods of fabricating semiconductor devices using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-12-13 US disclosed
CN-110831997-B Mixtures of radically curable compounds and their use 喜利得股份公司 2022-02-22 CN disclosed
US-20210300955-A1 MOLYBDENUM COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME ADEKA CORPORATION (JP) 2021-09-30 US disclosed
US-20200361970-A1 METAL COMPOUNDS AND METHODS OF FABRICATING SEMICONDUCTOR DEVICES USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300955-A1 MOLYBDENUM COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME INTS9, MCM5, INTS6 TSHR 3142/4885CYP1A2 669/4885CYP3A4 176/4885
US-20200361970-A1 METAL COMPOUNDS AND METHODS OF FABRICATING SEMICONDUCTOR DEVICES USING THE SAME GPX1, SLC39A11, FEM1B TSHR 4770/4885CYP1A2 932/4885CYP3A4 1807/4885
US-11524973-B2 Metal compounds and methods of fabricating semiconductor devices using the same GPX1, SLC39A11, FEM1B TSHR 4770/4885CYP1A2 932/4885CYP3A4 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.